Key result
Left-bundle branch area pacing was not shown to be non-inferior to biventricular pacing for positive CRT response at 6 months (89.7% vs 94.6%; RR 0.95; 95% CI 0.88-1.02).
Why the study?
Conduction system pacing has emerged as an alternative to biventricular pacing for CRT, but its non-inferiority in patients with typical LBBB was unknown.
Does left-bundle branch area pacing improve positive CRT response at 6-months compared to biventricular pacing in patients with guideline-based CRT indications and LBBB?
RCT (n=176)
Yes
Does left-bundle branch area pacing improve positive CRT response at 6-months compared to biventricular pacing in patients with guideline-based CRT indications and LBBB?
Relative Risk: 0.95 (95% CI 0.88–1.02)
Absolute Event Rate: 89.7% vs 94.6%
No takes yet. Share an insight, caveat, or question.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“We now have randomized data showing that [LBBAP] is a very credible CRT option, with procedural advantages in some settings and clinical outcomes that are at least broadly comparable to BiV-CRT in selected populations. But I would still be cautious about overinterpreting the current evidence. These trials are important, but they do not yet justify a one-size-fits-all conclusion that LBBAP should replace conventional CRT across the board.”
In patients with typical LBBB eligible for CRT, left-bundle branch area pacing was not shown to be non-inferior to biventricular pacing for achieving a positive CRT response at 6 months, although both strategies yielded high response rates.
BACKGROUND AND AIMS: Conduction system pacing has emerged as an alternative to biventricular pacing (BiVP) for cardiac resynchronization therapy (CRT). The left-bundle CRT trial evaluated whether left-bundle branch area pacing (LBBAP) is non-inferior to BiVP in patients eligible for CRT. METHODS: The left-bundle CRT trial was a multi-centre, randomized, investigator-initiated, and non-inferiority study. Patients with guideline-based CRT indications and left-bundle branch block per Strauss criteria were randomized to BiVP-CRT or LBBAP-CRT. The primary endpoint was the proportion of patients with a positive CRT response at 6-months, defined as either an improved clinical composite score (CCS) or a ≥15% reduction in left ventricular end-systolic volume. The non-inferiority margin was the lower bound of the 95% confidence interval (CI) and was set at 10%. Patients were followed for 12-months; secondary endpoints included echocardiographic, clinical, and quality-of-life outcomes. RESULTS: The baseline characteristics of the 176 patients randomized to BiVP-CRT (n=84) or LBBAP-CRT (n=92) were similar, except for a wider intrinsic QRS in the LBBAP group: median 172 ms [IQR 158-184] vs. 165 ms [152-180]; P=0.04. Crossovers occurred in 26 patients (14.9%). In the intention-to-treat analysis, the primary endpoint was achieved in 94.6% of BiVP-CRT and 89.7% of LBBAP-CRT patients (RR 0.95; 95% CI 0.88-1.02), not meeting non-inferiority. CCS improved in 77% and 68% of patients randomized to BiVP-CRT and LBBAP-CRT, respectively and 85% and 79% had a ≥15% reduction in left ventricular end-systolic volume. Rates of adverse events and heart failure hospitalization were similar between groups. CONCLUSIONS: In CRT candidates with typical LBBB, LBBAP-CRT was not shown to be non-inferior to BiVP-CRT. Both strategies yielded high response rates and similar clinical outcomes.
Journal, society, and media accounts. Useful signal, not independent expert judgment.
Cano et al. (2026) conducted an RCT in CRT candidates with typical LBBB (n=176). Left-bundle branch area pacing (LBBAP-CRT) vs. Biventricular pacing (BiVP-CRT) was evaluated on positive CRT response at 6-months, defined as either an improved clinical composite score (CCS) or a ≥15% reduction in left ventricular end-systolic volume (RR 0.95, 95% CI 0.88-1.02). Left-bundle branch area pacing was not shown to be non-inferior to biventricular pacing for positive CRT response at 6 months (89.7% vs 94.6%; RR 0.95; 95% CI 0.88-1.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: